Period:
Draw Mode:
| Volume | 34,667,001 |
|
|||||
| News | (6) | ||||||
| Day High | 2.07 | Low High |
|||||
| Day Low | 1.76 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Ginkgo Bioworks Holdings Inc | DNA | NYSE | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.08 | 4.62% | 1.81 | 14:54:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 1.94 | 1.76 | 2.07 | 1.73 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 45,442 | 34,667,001 | $ 1.83 | $ 63,340,376 | - | 1.12 - 3.52 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 14:54:33 | 3 | $ 1.815 | USD |
Ginkgo Bioworks Holdings Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 3.8B | 2.10B | - | 477.71M | -2.1B | -1.00 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Ginkgo Bioworks News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical DNA Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.84 | 2.07 | 1.71 | 1.77 | 15,242,816 | -0.03 | -1.63% |
| 1 Month | 2.20 | 2.465 | 1.71 | 2.04 | 19,116,898 | -0.39 | -17.73% |
| 3 Months | 1.77 | 2.545 | 1.55 | 2.05 | 21,460,998 | 0.04 | 2.26% |
| 6 Months | 1.28 | 2.545 | 1.12 | 1.77 | 21,264,167 | 0.53 | 41.41% |
| 1 Year | 2.90 | 3.52 | 1.12 | 1.92 | 22,202,325 | -1.09 | -37.59% |
| 3 Years | 11.24 | 15.864 | 1.12 | 3.10 | 19,956,512 | -9.43 | -83.9% |
| 5 Years | 11.24 | 15.864 | 1.12 | 3.10 | 19,956,512 | -9.43 | -83.9% |
Ginkgo Bioworks Description
| Ginkgo Bioworks Holdings Inc is building a platform to enable customers to program cells as easily to program computers. The company's platform is market agnostic and enables biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. |